These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 29736937)
81. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome. Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S Int J Cardiol; 2019 Jul; 287():87-95. PubMed ID: 30987834 [TBL] [Abstract][Full Text] [Related]
82. The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation. Liu J; Wang H; Wang Y; Yin Y; Du Z; Liu Z; Yang J; Hu S; Wang C; Chen Y J Cell Mol Med; 2014 Jul; 18(7):1381-91. PubMed ID: 24779911 [TBL] [Abstract][Full Text] [Related]
84. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990 [TBL] [Abstract][Full Text] [Related]
85. Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction. Xu H; Wang Z; Liu L; Zhang B; Li B J Cell Biochem; 2020 Mar; 121(3):2089-2102. PubMed ID: 31736169 [TBL] [Abstract][Full Text] [Related]
86. [Effects of marrow-derived cardiac stem cell transplantation after myocardial infarction in rats]. Zhang GT; Tan YZ; Wang HJ; Ao H; Guo HD; Huang GY Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):940-4. PubMed ID: 18206045 [TBL] [Abstract][Full Text] [Related]
87. Application of tissue-engineered pericardial patch in rat models of myocardial infarction. Kameli SM; Khorramirouz R; Eftekharzadeh S; Fendereski K; Daryabari SS; Tavangar SM; Kajbafzadeh AM J Biomed Mater Res A; 2018 Oct; 106(10):2670-2678. PubMed ID: 29901284 [TBL] [Abstract][Full Text] [Related]
88. Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction. Sonnenberg SB; Rane AA; Liu CJ; Rao N; Agmon G; Suarez S; Wang R; Munoz A; Bajaj V; Zhang S; Braden R; Schup-Magoffin PJ; Kwan OL; DeMaria AN; Cochran JR; Christman KL Biomaterials; 2015 Mar; 45():56-63. PubMed ID: 25662495 [TBL] [Abstract][Full Text] [Related]
89. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Behfar A; Hodgson DM; Zingman LV; Perez-Terzic C; Yamada S; Kane GC; Alekseev AE; Pucéat M; Terzic A Ann N Y Acad Sci; 2005 May; 1049():189-98. PubMed ID: 15965118 [TBL] [Abstract][Full Text] [Related]
90. Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair. Zhu D; Li Z; Huang K; Caranasos TG; Rossi JS; Cheng K Nat Commun; 2021 Mar; 12(1):1412. PubMed ID: 33658506 [TBL] [Abstract][Full Text] [Related]
91. Myocardial regeneration potential of adipose tissue-derived stem cells. Bai X; Alt E Biochem Biophys Res Commun; 2010 Oct; 401(3):321-6. PubMed ID: 20833143 [TBL] [Abstract][Full Text] [Related]
92. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Wang H; Shi J; Wang Y; Yin Y; Wang L; Liu J; Liu Z; Duan C; Zhu P; Wang C Biomaterials; 2014 Apr; 35(13):3986-98. PubMed ID: 24508080 [TBL] [Abstract][Full Text] [Related]
93. Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit. Hocine HR; Brunel S; Chen Q; Giustiniani J; San Roman MJ; Ferrat YJ; Palacios I; de la Rosa O; Lombardo E; Bensussan A; Charron D; Jabrane-Ferrat N; Al-Daccak R Stem Cells Transl Med; 2019 Sep; 8(9):911-924. PubMed ID: 30924311 [TBL] [Abstract][Full Text] [Related]
94. Cell-based therapies for the treatment of myocardial infarction: lessons from cardiac regeneration and repair mechanisms in non-human vertebrates. Palmquist-Gomes P; Pérez-Pomares JM; Guadix JA Heart Fail Rev; 2019 Jan; 24(1):133-142. PubMed ID: 30421074 [TBL] [Abstract][Full Text] [Related]
96. Thrombin and thrombin-derived peptides promote proliferation of cardiac progenitor cells in the form of cardiospheres without affecting their differentiation potential. Fabrizi C; Angelini F; Chimenti I; Pompili E; Somma F; Gaetani R; Messina E; Fumagalli L; Giacomello A; Frati G J Biol Regul Homeost Agents; 2011; 25(2 Suppl):S43-51. PubMed ID: 22051170 [TBL] [Abstract][Full Text] [Related]
97. Cardioprotective effects of genetically engineered cardiac stem cells by spheroid formation on ischemic cardiomyocytes. Jeong HS; Park CY; Kim JH; Joo HJ; Choi SC; Choi JH; Lim IR; Park JH; Hong SJ; Lim DS Mol Med; 2020 Jan; 26(1):15. PubMed ID: 32005100 [TBL] [Abstract][Full Text] [Related]
98. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Campan M; Lionetti V; Aquaro GD; Forini F; Matteucci M; Vannucci L; Chiuppesi F; Di Cristofano C; Faggioni M; Maioli M; Barile L; Messina E; Lombardi M; Pucci A; Pistello M; Recchia FA Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2238-50. PubMed ID: 21335465 [TBL] [Abstract][Full Text] [Related]
99. Mechanically induced pyroptosis enhances cardiosphere oxidative stress resistance and metabolism for myocardial infarction therapy. Wang Y; Li Q; Zhao J; Chen J; Wu D; Zheng Y; Wu J; Liu J; Lu J; Zhang J; Wu Z Nat Commun; 2023 Oct; 14(1):6148. PubMed ID: 37783697 [TBL] [Abstract][Full Text] [Related]
100. Generation of cardiomyocytes from stem cells cultured on nanofibrous scaffold: Experimental approach for attenuation of myocardial infarction. Aglan HA; Ahmed HH; Beherei HH; Abdel-Hady BM; Ekram B; Kishta MS Tissue Cell; 2024 Aug; 89():102461. PubMed ID: 38991272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]